Is there a generic for Cefmenoxime hydrochloride?

The FDA Orange Book does not currently list an approved generic (ANDA) for Cefmenoxime hydrochloride. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Cefmenoxime hydrochloride?

CEFMAX (NDA 050571, TAP PHARM) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Cefmenoxime hydrochloride are approved?

Cefmenoxime hydrochloride is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Cefmenoxime hydrochloride

Cefmenoxime hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:CEFMAX · NDA 050571

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
CEFMAX×3	TAP PHARM	NDA 050571	—	Dec 30, 1987

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cefmenoxime hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo